An integrative ChIP-chip and gene expression profiling to model SMAD regulatory modules

Human Cancer Genetics Program, Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, OH 43210, USA.
BMC Systems Biology (Impact Factor: 2.85). 08/2009; 3(1):73. DOI: 10.1186/1752-0509-3-73
Source: PubMed

ABSTRACT The TGF-beta/SMAD pathway is part of a broader signaling network in which crosstalk between pathways occurs. While the molecular mechanisms of TGF-beta/SMAD signaling pathway have been studied in detail, the global networks downstream of SMAD remain largely unknown. The regulatory effect of SMAD complex likely depends on transcriptional modules, in which the SMAD binding elements and partner transcription factor binding sites (SMAD modules) are present in specific context.
To address this question and develop a computational model for SMAD modules, we simultaneously performed chromatin immunoprecipitation followed by microarray analysis (ChIP-chip) and mRNA expression profiling to identify TGF-beta/SMAD regulated and synchronously coexpressed gene sets in ovarian surface epithelium. Intersecting the ChIP-chip and gene expression data yielded 150 direct targets, of which 141 were grouped into 3 co-expressed gene sets (sustained up-regulated, transient up-regulated and down-regulated), based on their temporal changes in expression after TGF-beta activation. We developed a data-mining method driven by the Random Forest algorithm to model SMAD transcriptional modules in the target sequences. The predicted SMAD modules contain SMAD binding element and up to 2 of 7 other transcription factor binding sites (E2F, P53, LEF1, ELK1, COUPTF, PAX4 and DR1).
Together, the computational results further the understanding of the interactions between SMAD and other transcription factors at specific target promoters, and provide the basis for more targeted experimental verification of the co-regulatory modules.

Download full-text


Available from: Louise Showe, Jul 22, 2015
1 Follower
  • Source
    • "With the exception of the progesterone receptor signature (which utilized the CLAUS PGR POSITIVE MENINGIOMA (Claus et al., 2008) signature from MSigDB-c2, version 3.1), oncogenic signatures were defined using the following gene lists from MSigDB-c6 (Liberzon et al., 2011, version 3.1) for GSEA analysis: TGFB UP.V1 (Padua et al., 2008), MTOR UP.N4.V1 (Wei et al., 2006), P53 DN.V2 (Elkon et al., 2005), and BRCA DN.V1 (Furuta et al., 2006). GSEA (Subramanian et al., 2005, version 2.0) calculated p-values by permutation over phenotypes whenever possible (Anders et al., 2008; Chin et al., 2006; Claus et al., 2008; Elkon et al., 2005; Finak et al., 2008; Huang et al., 2003; Padua et al., 2008; Sartor et al., 2010; Scandura et al., 2004; The Cancer Genome Atlas Network, 2012; Wei et al., 2006), although there were a few datasets with less than 3 replicates for which gene sets had to be permuted instead of phenotypes (Furuta et al., 2006; Qin et al., 2009; Renzoni et al., 2004). For recovery of known perturbations of oncogenic regulators, GSEA results must either show a FWER p-value < 0.25 or a NOM p-value < 0.05, which are the default cut-offs. "
    [Show abstract] [Hide abstract]
    ABSTRACT: BD-Func (BiDirectional FUNCtional enrichment) is an algorithm that calculates functional enrichment by comparing lists of pre-defined genes that are known to be activated versus inhibited in a pathway or by a regulatory molecule. This paper shows that BD-Func can correctly predict cell line alternations and patient characteristics with accuracy comparable to popular algorithms, with a significantly faster run-time. BD-Func can compare scores for individual samples across multiple groups as well as provide predictive statistics and receiver operating characteristic (ROC) plots to quantify the accuracy of the signature associated with a binary phenotypic variable. BD-Func facilitates collaboration and reproducibility by encouraging users to share novel molecular signatures in the BD-Func discussion group, which is where the novel progesterone receptor and LBH589 signatures from this paper can be found. The novel LBH589 signature presented in this paper also serves as a case study showing how a custom signature using cell line data can accurately predict activity in vivo. This software is available to download at
    PeerJ 09/2013; 1:e159. DOI:10.7717/peerj.159 · 2.10 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: "Epigenetic plasticity" refers to the capability of mammalian cells to alter their differentiation status via chromatin remodeling-associated alterations in gene expression. While epigenetic plasticity has been best associated with lineage commitment of embryonic stem cells, recent studies have demonstrated chromatin remodeling even in terminally differentiated normal cells, and advanced-stage melanoma and breast cancer cells, in context-dependent responses to alterations in their microenvironment. In the current study, we extend this attribute of epigenetic plasticity to aggressive ovarian cancer cells, by using an integrative approach to associate cellular phenotypes with chromatin modifications ("ChIP-chip") and mRNA and microRNA expression. While we identified numerous gene promoters possessing the well-known "bivalent mark" of H3K27me3/H3K4me2, we also report 14 distinct, lesser-known bi-, tri-, and tetravalent combinations of activating and repressive chromatin modifications, in platinum-resistant CP70 ovarian cancer cells. The vast majority (>90%) of all the histone marks studied localized to regions within 2000 bp of transcription start sites, supporting a role in gene regulation. Upon a simple alteration in the microenvironment, transition from two- to three-dimensional culture, an increase (17% to 38%) in repressive-only marked promoters was observed, concomitant with a decrease (31% to 21%) in multivalent (i.e., juxtaposed permissive and repressive histone marked) promoters. Like embryonic/tissue stem and other (non-ovarian) carcinoma cells, ovarian cancer cell epigenetic plasticity reflects an inherent transcriptional flexibility for context-responsive alterations in phenotype. It is possible that this plasticity could be therapeutically exploited for the management of this lethal gynecologic malignancy.
    Epigenetics: official journal of the DNA Methylation Society 11/2010; 5(8):716-29. DOI:10.4161/epi.5.8.13014 · 5.11 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In this paper, a UPF power conditioner for an optimal extraction of output power from grid connected variable speed wind energy conversion system (VSWECS) is presented. The system consists of a variable speed wind turbine coupled to a permanent magnet synchronous generator (PMSG) through a gear box, two PWM power converters and a maximum power point tracker (MPPT). Output power from PMSG is first converted into DC, inverted and then it is fed to the grid. Both the power conversions are performed at unity power factor and the DC link voltage is maintained constant. PWM rectifier is controlled based on the principle to shape the phase current as phase voltage and PWM inverter is controlled by a hysteresis current controller. The control algorithm is implemented on TMS320F243 DSP and the viability of the scheme is confirmed through experimental studies. The complete system has been simulated for various wind velocities. Typical simulation and experimental results are presented.
    Power Electronics Systems and Applications, 2004. Proceedings. 2004 First International Conference on; 12/2004
Show more